Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00452569
Status:
COMPLETED
Last Update Posted:
2019-11-18
First Post:
2007-03-23
Brief Title:
Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma
Sponsor:
Celgene
Organization:
Celgene
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Multiple Myeloma |
Keywords:
| Name | View |
|---|---|
| Relapsed Refractory Multiple Myeloma | View |